102 related articles for article (PubMed ID: 28933097)
21. Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system.
Ammar HO; Ghorab MM; Mahmoud AA; Higazy IM
Eur J Pharm Sci; 2018 Mar; 115():77-87. PubMed ID: 29341900
[TBL] [Abstract][Full Text] [Related]
22. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
23. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
[TBL] [Abstract][Full Text] [Related]
24. Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats.
Liu XD; Zhang L; Xie L
Eur J Drug Metab Pharmacokinet; 2003; 28(4):309-13. PubMed ID: 14743973
[TBL] [Abstract][Full Text] [Related]
25. Effect of Xiongbing compound on the pharmacokinetics and brain targeting of tetramethylpyrazine.
Wang LS; Shi ZF; Zhang YF; Guo Q; Huang YW; Zhou LL
J Pharm Pharmacol; 2012 Nov; 64(11):1688-94. PubMed ID: 23058057
[TBL] [Abstract][Full Text] [Related]
26. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study on pharmacokinetics of tetramethylpyrazine, ferulic acid and their compatibility].
Feng B; Zhang J; Zhang J; Chen G; Xu X
Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):900-3. PubMed ID: 20575396
[TBL] [Abstract][Full Text] [Related]
28. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
30. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution.
Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M
Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles.
Ngaboni Okassa L; Marchais H; Douziech-Eyrolles L; Cohen-Jonathan S; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2005 Sep; 302(1-2):187-96. PubMed ID: 16099119
[TBL] [Abstract][Full Text] [Related]
32. Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release.
Mandal B; Halder KK; Dey SK; Bhoumik M; Debnath MC; Ghosh LK
Pharmazie; 2009 Jul; 64(7):445-9. PubMed ID: 19694181
[TBL] [Abstract][Full Text] [Related]
33. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
34. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of nanoparticles based on mPEG-PLA for controlled delivery of vinpocetine: in vitro and in vivo studies.
Wang R; Xu Y
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):157-162. PubMed ID: 26838484
[TBL] [Abstract][Full Text] [Related]
37. PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury.
Ruozi B; Belletti D; Sharma HS; Sharma A; Muresanu DF; Mössler H; Forni F; Vandelli MA; Tosi G
Mol Neurobiol; 2015 Oct; 52(2):899-912. PubMed ID: 26108180
[TBL] [Abstract][Full Text] [Related]
38. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
39. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
[TBL] [Abstract][Full Text] [Related]
40. Development and pharmacokinetics of nimodipine-loaded liposomes.
Wang Z; Deng Y; Zhang X; Wang T; Wu F
J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]